Posts
Automakers report stellar sales ahead of Trump's tariffs taking effect
Atlanta Fed drops -1.4% (adjusted) GDP growth estimate for Q1
"The GDPNow model estimate for real GDP growth (seasonally adjusted annual rate) in the first quarter of 2025 is **-3.7 percent** on April 1, down from -2.8 percent on March 28. The **alternative model forecast**, which adjusts for imports and exports of gold as described [here](https://www.atlantafed.org/-/media/documents/cqer/researchcq/gdpnow/ModificationsToGDPNowModel.pdf), is **-1.4 percent**. After …
Almost $15k in TSLA puts let’s hope for the best (or worst)
Why is no investing in the cruise lines?
These companies are all trading below a 20 P/E. NCLH trading at below 11 P/E. RCL at 18. CCL at 12. They are not the sexiest stocks but you can see guidance pretty clearly. All three show 100% booking capacity for 2025. YOY growth is solid from all three. They …
[YOLO DD] $NRDS – NerdWallet 🚀
Alright you greasy-fingered gamblers, it’s time. This is your early heads-up on a sleeper banger: NerdWallet ($NRDS). THE SETUP: - Current Price: $9.28 - EPS Estimate: $0.24 (reporting 4/24) - Market Conditions: ??? - Sentiment: Dead. Zero hype. Beautiful. They don’t need a blowout to move big — they just …
Hims & Hers to sell Lilly's Zepbound on its telehealth platform
(Reuters) -Telehealth firm Hims & Hers Health said on Monday it plans to sell Eli Lilly's weight-loss drug Zepbound on its platform. Shares of the company were up 8.5% in afternoon trading.